About Aspivix
Aspivix is a company based in Lausanne (Switzerland) founded in 2015 by Mathieu Horras and Julien Elie Finci.. Aspivix has raised $7.01 million across 9 funding rounds from investors including Zurcher Kantonalbank, European Union and Eureka Network. Aspivix offers products and services including Carevix. Aspivix operates in a competitive market with competitors including Daré Bioscience, Femasys, Adiana, Uteron Pharma and RemovAid, among others.
- Headquarter Lausanne, Switzerland
- Founders Mathieu Horras, Julien Elie Finci
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aspivix Sa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.01 M (USD)
in 9 rounds
-
Latest Funding Round
$5 M (USD), Series A
Nov 17, 2022
-
Investors
Zurcher Kantonalbank
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aspivix
Aspivix offers a comprehensive portfolio of products and services, including Carevix. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Suction-based tool to stabilize cervix and reduce pain in procedures
Unlock access to complete
Unlock access to complete
Funding Insights of Aspivix
Aspivix has successfully raised a total of $7.01M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series A — $5.0M
-
First Round
First Round
(01 Jun 2017)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Grant - Aspivix | Valuation |
investors |
|
| Nov, 2022 | Amount | Series A - Aspivix | Valuation | HEMEX | |
| Oct, 2021 | Amount | Grant - Aspivix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aspivix
Aspivix has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, European Union and Eureka Network. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Regulatory affairs and marketing services are provided for healthcare entities.
|
Founded Year | Domain | Location | |
|
Early stage investments in Swiss healthcare and technology are facilitated.
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aspivix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aspivix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aspivix Comparisons
Competitors of Aspivix
Aspivix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Daré Bioscience, Femasys, Adiana, Uteron Pharma and RemovAid, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-hormonal pharmaceutical products for female contraceptives are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for women's healthcare are developed and provided.
|
|
| domain | founded_year | HQ Location |
Transcervical sterilization systems for permanent birth control are developed.
|
|
| domain | founded_year | HQ Location |
Develops products dedicated to female healthcare solutions.
|
|
| domain | founded_year | HQ Location |
Medical devices for subdermal implant removal are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aspivix
Frequently Asked Questions about Aspivix
When was Aspivix founded?
Aspivix was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Aspivix located?
Aspivix is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Who is the current CEO of Aspivix?
Mathieu Horras is the current CEO of Aspivix. They have also founded this company.
Is Aspivix a funded company?
Aspivix is a funded company, having raised a total of $7.01M across 9 funding rounds to date. The company's 1st funding round was a Grant of $57.8K, raised on Jun 01, 2017.
What does Aspivix do?
Aspivix was founded in 2015 in Lausanne, Switzerland, as a medtech company focused on gynecological devices. A suction-based tool called Carevix is developed to facilitate intrauterine contraceptive placement. The cervix is gently opened via vacuum application, minimizing pain and bleeding in procedures. Operations center on innovation in womens health solutions, with products targeted at clinical use in reproductive care settings.
Who are the top competitors of Aspivix?
Aspivix's top competitors include Daré Bioscience, Femasys and RemovAid.
What products or services does Aspivix offer?
Aspivix offers Carevix.
Who are Aspivix's investors?
Aspivix has 9 investors. Key investors include Zurcher Kantonalbank, European Union, Eureka Network, Launchpad, and HEMEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.